Addressing this gap, this review offers three integrated contributions: first, it positions ferroptosis as a convergent metabolic executioner across a broader spectrum of kidney diseasesencompassing AKI, DN, renal interstitial fibrosis, systemic lupus erythematosus (SLE) nephritis, autosomal dominant polycystic kidney disease (ADPKD), renal cell carcinoma (RCC), and contrast-induced nephropathy (CIN)while emphasizing cell type-specific vulnerabilities: tubular epithelial cells (susceptible via mitochondrial dysfunction), podocytes (via iron overload), and immune cells (e.g., neutrophils/macrophages in SLE nephritis) exhibit context-dependent ferroptosis regulation, governed by cell type-specific modulators [e.g., Nrf2 in tubules, heme oxygenase-1 (HO-1) in macrophages, and sirtuins in podocytes]
The maximum current it can deliver is 1C * 50
Figure 1 3.3 Signaling regulatory networks of the gut microbiota-gut-liver axis 3.3.1 Bile acid receptor (FXR, TGR5) signaling pathways Bile acids function not only as digestive molecules but also as important metabolic regulatory signaling molecules
168 A large meta-analysis of 65 randomized controlled trials with 7,887 hypertensive subjects found folic acid plus blood pressure-lowering medication was more effective than medication alone for lowering blood pressure, lowering homocysteine levels, and reducing risk of cardiovascular events and stroke by 13% compared with control groups
